Funder
National Natural Science Foundation of China
State Key Laboratory of Natural Medicines and Active Substance
Ministry of Education
Liaoning Innovative Research Team
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference42 articles.
1. Update on tubulin-binding agents;Attard;Pathol. Biol.,2006
2. Microtubules as a target for anticancer drugs;Jordan;Nat. Rev. Cancer,2004
3. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4;Pettit;Experientia,1989
4. A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer;Dowlati;Cancer Res.,2002
5. Vascular disrupting agents: a new class of drug in cancer therapy;Gaya;Clin. Oncol.,2005
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献